58 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
2022, and Performance Health, a consumer health care product manufacturing company, from 2015 to 2016. Mr. Celano holds a B.S. in Accounting from St
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
Adverse Effect.
(hh) Compliance with Health Care Laws. The Company and, to the Company’s knowledge, its directors, employees and agents (while acting … in such capacity) are and at all times have been in material compliance with, all health care laws applicable to the Company, or any of its products
424B5
LRMR
Larimar Therapeutics Inc
14 Feb 24
Prospectus supplement for primary offering
5:08pm
of health care payment systems;
adverse regulatory decisions;
trading volume of our common stock;
period-to-period fluctuations in our financial results
424B5
qwlyqn1btym1awl5d
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-1.1
89qcd
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
okaypxo
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-10.1
d19r sqzaa
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K/A
EX-99.2
qexoxncwdrc28uq hqm
26 Jun 20
Other Events
5:08pm
D
op15emy mo
10 Jun 20
$82.08M in equity, sold $82.08M, 1 investor
1:02pm